FlareHawk Logo
Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted
11 oct. 2022 08h45 HE | Accelus
PALM BEACH GARDENS, Fla., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Two TiHawk11 devices implanted via a posterior approach to create a 34mm-wide footprint within the disc space
Accelus Announces First Surgeries Using FlareHawk® TiHawk11™ Interbody Fusion System
15 août 2022 08h59 HE | Accelus
New expandable interbody enables up to a 34mm-wide footprint from a posterior approach with up to 2cm2 of bone graft contact area through the implant PALM BEACH GARDENS, Fla., Aug. 15, 2022 ...
EB Headshot VSON Logo
Accelus Announces Vail-Summit Orthopaedics and Neurosurgery as First Ambulatory Surgery Center to Adopt Remi™ Robotic Navigation System
14 juil. 2022 12h37 HE | Accelus
PALM BEACH GARDENS, Fla., July 14, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
accelus-logo_4c.png
Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP
12 juil. 2022 08h15 HE | Accelus
• CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH GARDENS, Fla., July 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology...
Lisa Jacobs, Accelus VP of Sales
Accelus Announces Sales Leadership Appointments, Establishes U.S. East and West Sales Leaders
13 juin 2022 08h45 HE | Accelus
Lisa Jacobs promoted to serve as Vice President of SalesJim Fox promoted to East U.S. Vice President of SalesJay Shellhammer promoted to West U.S. Vice President of Sales PALM BEACH GARDENS, Fla.,...
Toro-L Interbody Fusion System
Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System
19 mai 2022 08h35 HE | Accelus
PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
th11_web
Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System
12 mai 2022 08h25 HE | Accelus
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus launches the TiHawk7 Titanium-Bonded Multidirectionally Expanding Interbody Case to Support Endoscopic and MIS Lumbar Fusion Procedures
Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures
05 mai 2022 08h20 HE | Accelus
PALM BEACH GARDENS, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in...
accelus-logo_4c.png
Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award
02 mai 2022 08h45 HE | Accelus
PALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Tien V. Le, M.D.
Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies
21 avr. 2022 08h00 HE | Accelus
PALM BEACH GARDENS, Fla., April 21, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...